4//SEC Filing
Cieplinska Agnieszka 4
Accession 0001179110-20-001466
CIK 0001235010other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:00 PM ET
Size
8.2 KB
Accession
0001179110-20-001466
Insider Transaction Report
Form 4
Cieplinska Agnieszka
Chief Accounting Officer (PAO)
Transactions
- Award
Stock Option (Right to Buy)
2020-02-07+16,313→ 16,313 totalExercise: $31.87Exp: 2030-02-07→ Common Stock (16,313 underlying) - Award
Restricted Stock Units
2020-02-07+8,193→ 8,193 total→ Common Stock (8,193 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- [F2]Represents restricted stock units granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
- [F3]Subject to the officer continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
- [F4]Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
- [F5]Subject to certain criteria, the stock option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001798748
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:00 PM ET
- Size
- 8.2 KB